Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Recognize warning signs your budget is bad and learn practical tweaks to restore balance and reliability.
19,039 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
I’m a fan of Costco as a retailer, but my investing stance is stubbornly conservative. Here’s the core reason haven't...
NuScale Power has seen wild swings, but the story isn’t just nostalgia for a boom. This piece breaks down the odds of...
Tech names surged as AI infrastructure demand strengthens revenue outlook. This article breaks down what happened, wh...
A mid-February 2026 SEC filing shows Bank Hapoalim taking a new position in the FTCS ETF, worth about $14.7 million. ...
Eli Lilly has enjoyed rapid growth from GLP-1 drugs, but sky-high expectations invite questions about valuations. Thi...
Tower Semiconductor stock jumped today as investors cheered a breakthrough with Coherent that could speed AI data cen...
The crypto market has cooled from its peaks, but two names consistently draw attention: Ethereum and Solana. This gui...
HF Foods (HFFG) faces a pivotal year as Q1 2026 results unfold. This guide breaks down what to watch, how to interpre...
Fermi’s stock jump today highlights how earnings, project milestones, and strategic pivots shape appetite for AI infr...
Rivian sits at a pivotal crossroads. This in-depth look weighs cash, partnerships, and a road map for growth to answe...
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...